Monoclonal anti-I-A antibody reverses chronic paralysis and demyelination in Theiler's virus-infected mice: Critical importance of timing of treatment

A. Friedmann, G. Frankel, Y. Lorch, L. Steinman

Research output: Contribution to journalArticlepeer-review

69 Scopus citations

Abstract

Susceptibility to demyelination caused by the WW isolate of Theiler's murine encephalomyelitis viruses is linked to class II genes of the major histocompatibility complex. SJL/J (H-2(s)) mice, expressing only I-A(s) class II gene products of the major histocompatibility complex, are highly susceptible to Theiler's murine encephalomyelitis virus infection with the WW virus isolate, with chronic paralysis and severe inflammation and demyelination in the central nervous system. The effect of in vivo administration of anti-I-A(s) monoclonal antibodies on Theiler's murine encephalomyelitis virus infection was observed. SJL/J mice were treated in various protocols pre- or postinfection. Anti-I-A(s) monoclonal antibody reversed chronic paralysis and reduced inflammation and demyelination when given after the establishment of persistent infection. The effect was long lasting, but clinical signs, inflammation, and demyelination recurred 2 months after treatment ceased. Anti-I-A(s) antibodies had no effect on viral titers within the central nervous system. The timing of the administration of monoclonal antibodies was critical. Administration of anti-I-A(s) before the establishment of the persistent infection resulted in fatal encephalitis.

Original languageEnglish
Pages (from-to)898-903
Number of pages6
JournalJournal of Virology
Volume61
Issue number3
DOIs
StatePublished - 1987

Fingerprint

Dive into the research topics of 'Monoclonal anti-I-A antibody reverses chronic paralysis and demyelination in Theiler's virus-infected mice: Critical importance of timing of treatment'. Together they form a unique fingerprint.

Cite this